D
espite an emphasis on early detection and treatment, breast cancer remains a significant public health problem. It continues to be the most frequently diagnosed non--skin cancer malignancy and the second leading cause of cancer-related death in women. In 2007, an estimated 180,000 women were diagnosed with invasive breast cancer. 1 During this same period, the rate of aesthetic breast surgery increased nearly 60 percent, 2 with more than 550,000 women undergoing cosmetic breast procedures in the past year alone. 2 This places plastic surgeons in a position to improve rates of preoperative breast cancer screening, as most women presenting for aesthetic breast surgery are also in the demographic group that is at risk for breast cancer. Further, aesthetic breast surgery is associated with irreversible changes to the architecture of the breast parenchyma, increasing the importance of presurgical screening in this population.
Much discussion and investigation have surrounded which breast cancer screening should be performed in postoperative aesthetic surgery patients. [3] [4] [5] [6] [7] [8] [9] [10] [11] Breast implants used in augmenta-tion mammaplasty can obscure portions of breast tissue during subsequent mammography screening [12] [13] [14] and, therefore, have the potential to reduce the sensitivity and specificity of the test. 7, 15, 16 Implants may compress glandular tissue and cause capsule formation with microcalcification, events that can mask or mimic architectural change associated with malignancy. Even with displacement mammography techniques, studies have shown that mammography results may remain difficult to interpret in these patients, 17 as implants may still reduce the amount of tissue visualized by up to 25 percent. 4 Interestingly, although detection by mammography is decreased, most available evidence implies that women with implants who later develop cancer tend to present at similar stages compared with those without implants. 6,8,18 -20 In addition, these women more often present with palpable masses. 6, 15, 19 The implant itself may facilitate the clinical breast examination 6 and therefore may offset the difficulties with the interpretation of mammograms. These factors may account for the fact that implants have not been shown to affect survival. 8 Patients who undergo reduction mammaplasty have routine cancer screening through the procedure itself, as the surgical specimens are commonly sent to pathology for histologic examination. 4 If the specimens are not oriented and contain a suspicious finding, subsequent completion mastectomy is frequently required due to the repositioning of the breast parenchyma during the reconstruction. 21 In addition, postreduction mammograms have shown consistent architectural changes within the reconstruction. 10, 11, 22 In general, breast reductions decrease the risk for cancer as breast tissue is removed, but resulting changes in the mammogram can mimic malignancy and have the potential to make future screening studies difficult to interpret. 4 While studies exist on postoperative cancer screening in the aesthetic surgery population, few articles specifically address recommendations for preoperative screening in this population. In the limited body of literature that addresses screening before cosmetic breast surgery, approaches most commonly echo the American Cancer Society Guidelines for Breast Cancer Screening. 23 These guidelines include yearly mammography for average-risk women age 40 and above, with clinical breast examinations for asymptomatic women beginning at age 20 and occurring at least every 3 years until age 40 and yearly after age 40. The guidelines also suggest that patients be educated on breast self-exams beginning at age 20. 23 In addition, for certain high-risk individuals, including those with BRCA mutations, those who are first-degree relatives of BRCA mutation carriers, and those with a calculated high risk for cancer, yearly magnetic resonance screening is now recommended. 24 It is not known how closely these guidelines are followed by plastic surgeons before aesthetic breast surgery or if plastic surgeons routinely follow other screening practices not supported by data or recommended by mainstream medical organizations.
Approximately 60 percent of aesthetic breast procedures were performed in patients 40 years old or younger. 2 Unless they possess risk factors for early breast cancer, these patients are not recommended for screening mammography under current American Cancer Society guidelines. Whether there is an opportunity or obligation for the plastic surgery community to perform such screening in patients under 40 is an open question. There are currently no data to suggest that such screening results in identification of early breast cancer or lowers breast cancer mortality rates in this patient subpopulation.
The goal of this study was to determine the self-reported breast cancer screening practices of American plastic surgeons and determine the degree to which those practices adhere to guidelines set forth by the American Cancer Society. Subgroup analyses of plastic surgeons divided by gender, length of time in practice, and practice setting also were performed.
METHODS AND STUDY DESIGN
The authors conducted an online survey of the members of the American Society of Plastic Surgeons. The 20 multiple-choice questions (Tables 1  and 2 ) were designed to assess physician practice composition and familiarity with American Cancer Society guidelines, and to ascertain specific practices for preoperative evaluation and breast cancer screening in patients seeking aesthetic breast surgery. The survey comprised four components: general practice information, breast cancer screening practice, criteria for obtaining breast cancer screening, and criteria for further evaluation of breast cancer risk. The survey was administered through the online survey application Survey Monkey over a 5-month period (January of 2008 to May of 2008). E-mails were sent to the 4520 society members, with an initial distribution followed by two additional distributions to nonresponders.
Survey responses were tallied and summarized using descriptive statistics (frequencies and percentages). Pearson's chi-square test or Fisher's ex- 
RESULTS

Response Rate and Demographics
A total of 1094 plastic surgeons participated in the survey (24 percent response rate). Twentyeight responses were excluded because these surgeons responded that they "do not do breast surgery," "do not operate," "are pediatric surgeons," "are retired," or "work with cancer patients only" on an initial screening question. The 1066 included respondents were predominantly male (82 percent) and consisted largely of private practitioners (73 percent). The participants were roughly evenly distributed with respect to total years in practice, and a majority of surgeons performed augmentation mammaplasty, reduction mammaplasty, and mastopexy (96 percent). We attempted, but were unable, to obtain data regarding the mentioned variables for the total American Cancer Society member population.
Overall Results
Most respondents attested to always reviewing risk factors preoperatively in their aesthetic breast surgery patients (89 percent), and only slightly fewer always perform a clinical breast examination preoperatively (86 percent). Eighty-nine percent of respondents claimed that they obtain mammographic screening based on age, and 57 percent do so based on positive family history, regardless of age. When prompted on the practice of obtaining a mammogram based on American Cancer Society breast screening guidelines, 61 percent stated that they did follow the guidelines, whereas 24 percent stated that they did not know the guidelines. The overall use of mammography varied greatly, with 7 percent (n ϭ 78) of respondents screening 100 percent of patients, 24 percent (n ϭ 254) screening 76 to 99 percent of patients, 50 percent (n ϭ 531) screening 26 to 75 percent of patients, 15 percent (n ϭ 159) screening 1 to 25 percent of patients, and 0.1 percent (n ϭ 10) never screening. The age at which routine preoperative mammography was initiated varied as well, but the largest percentage of surgeons stated that they screen beginning at age 40; most of the remainder stated that they screened beginning at a younger age (Table 2) . Seventy-five percent (n ϭ 799) of plastic surgeons considered a mammogram within 1 year to be valid, whereas 15 percent (n ϭ 166) stated that this was age dependent. In total, 47 percent (n ϭ 502) of the physicians surveyed appeared to follow the American Cancer Society guidelines, while 64 percent (n ϭ 680) claimed familiarity with the recommendations.
Over 90 percent (n ϭ 963) of survey respondents reported obtaining an oncology consult in less than 25 percent of patients. These surgeons were much more likely to obtain a consult, usually surgical, if screening revealed a positive finding. Even in patients with a positive family history, most respondents stated that they would not obtain a consult. A minority utilized other screening mo- dalities in addition to mammography, including magnetic resonance imaging and ultrasound. Fifty-six percent of respondents (n ϭ 598) had never had a patient diagnosed with ductal carcinoma in situ during or within a year of an aesthetic procedure, whereas 24 percent (n ϭ 260) had up to two patients diagnosed during that period.
Subgroup Results
Years in Practice
Physicians who had been in practice for more than 15 years were more likely than less experienced physicians to report that they perform clinical examinations in all patients (92 versus 86 percent, p ϭ 0.007); however, the physicians with fewer than 15 years in practice more often obtained a mammogram based on age (94 versus 90 percent, p ϭ 0.02). These less-experienced physicians also reported initiating mammography screening at younger ages (p Ͻ 0.001; Table 2 ). A higher percentage of physicians in practice fewer than 15 years stated that mammography was valid within 1 year (82 versus 71 percent, p Յ 0.001). Physicians with more than 15 years of experience less commonly ordered oncology consults in their patients, with 57 versus 50 percent stating that they never do (p ϭ 0.02), but these physicians were more likely to use additional studies to screen for breast cancer (49 versus 39 percent, p ϭ 0.004). With respect to utilization of other screening modalities, multivariate logistic regression comparing greater than 15 years in practice to less than 15 years in practice also predicted a similar result, with an odds ratio of 1.65 (p ϭ 0.001, Tables  3 through 5) . A higher percentage of more experienced physicians reported having had any patient diagnosed with breast cancer during or within a year of their cosmetic procedure (39 versus 32 percent, p ϭ 0.035), and the multivariate logistic regression also predicted an increased odds of having a patient diagnosed with breast cancer during or within a year of the procedure in this group (odds ratio 1.48, p ϭ 0.007).
Physician Gender Female respondents to this survey stated that they were more likely to obtain a mammogram based on age (96 versus 91 percent, p ϭ 0.03). A higher percentage of women surgeons reported that they obtained mammograms in more than 75 percent of their patients (44 versus 30 percent, p Յ 0.001), initiated screening at younger ages (p ϭ 0.01, Table 2 ), and screened with other modalities, compared with their male counterparts (52 versus 41 percent, p ϭ 0.01). Multivariate logistic regression further confirms this last relationship (odds ratio 1.75, p ϭ 0.002). Although mammography was utilized to a greater extent by female than by male physicians, 59 percent of female plastic surgeons did not follow American Cancer Women surgeons also reported that they were more likely to obtain preoperative oncology consultations (55 versus 46 percent, p ϭ 0.03). Finally, a higher percentage of women indicated having had one or more patients diagnosed with breast cancer during or within a year of the procedure (44 versus 33 percent, p ϭ 0.004), and a multivariate logistic regression model demonstrated that being a female surgeon was predictive of having had one or more patients diagnosed during or within a year of a cosmetic breast procedure (odds ratio 1.76, p ϭ 0.002).
Practice Setting
Academic physicians tended to report obtaining mammograms in more of their patients compared with physicians in private practice, although this difference did not reach statistical significance (38 versus 30 percent, p ϭ 0.06). Academic plastic surgeons did report being significantly more likely to obtain preoperative oncology consults for patients (59 versus 44 percent, p ϭ 0.001). A multivariate linear regression further confirms this association, utilizing the academic physicians as a reference group (odds ratio 0.56, p Ͻ 0.01). In addition, academic physicians were significantly more likely to report obtaining mammography based on a positive family history (37 versus 22 percent, p Ͻ 0.001). Finally, private practice physicians were more likely to report utilizing other screening methods in addition to mammography (43 versus 32 percent, p ϭ 0.015), and a multivariate logistic regression also predicted these findings (odds ratio 1.55, p ϭ 0.03).
Familiarity with American Cancer Society Guidelines
Surgeons who answered that they were familiar with the American Cancer Society screening guidelines were more likely to review risk factors preoperatively in all patients (94 versus 85 percent, p Յ 0.001) and were more likely to perform a clinical breast examination in 100 percent of their patients (90 versus 86 percent, p ϭ 0.04). A higher percentage of respondents familiar with American Cancer Society guidelines obtained a mammogram based on age (94 versus 88 percent, p Յ 0.001), obtained a mammogram based on the American Cancer Society guidelines (87 versus 15 percent p Յ 0.001), and obtained a preoperative oncology consult for any of their patients (52 versus 38 percent, p Յ 0.001). The association with preoperative oncology consultation was further confirmed by multivariate linear regression (odds ratio 1.72, p Ͻ 0.001). Fewer of these surgeons considered mammography to be valid within 1 year (76 versus 82 percent, p ϭ 0.03), and surgical consultation was utilized to a greater extent and medical consultation to a lesser extent when abnormal findings were noted, compared with surgeons not familiar with American Cancer Society ( Table 2 ; p ϭ 0.045). Surgeons familiar with the guidelines more often obtained additional screening tests (47 versus 35 percent, p ϭ 0.001), and a higher percentage had patients diagnosed with ductal carcinoma in situ during or within a year after surgery (38 versus 28 percent, p ϭ 0.003). The multivariate logistic regression predicted similar associations for these outcomes when comparing those familiar with the guidelines to those unfamiliar, with an odds ratio of 1.56 (p ϭ 0.004) for obtaining additional screening studies and 1.61 for having a patient diagnosed during or within a year of the procedure (p ϭ 0.002).
DISCUSSION
Plastic surgeons are in a unique position to intervene in the lives of women who may not otherwise be receiving appropriate screening for breast cancer. Effective intervention requires knowledge and application of existing evidencebased guidelines. Screening recommendations have changed over the last decade. In 1997, the American Cancer Society updated its guidelines for breast cancer screening. 25 The most promi- nent modification to previous guidelines was the recommendation that women should begin annual screening mammography at age 40, as opposed to every 1 to 2 years, beginning at age 40 and annually after age 50. 26 Recommendations for clinical breast examination were changed to advise women beginning at age 40 to schedule a clinical breast examination annually around the time of mammography.
In 2002, the American Cancer Society convened a panel of experts to review existing guidelines and relevant literature to more closely align recommendations with available evidence. The results of these deliberations were published in 2003, with recommendations for women at average risk and women at increased risk (Table 6) . 23 Women at average risk should begin mammography at age 40 and should receive a clinical breast examination at least every 3 years beginning in their 20s and 30s. Beginning in their 20s, these women should also receive education on the benefits and limitations of breast self-examination. At that time, it was stated that women at increased risk of breast cancer might benefit from additional screening strategies, such as ultrasound or magnetic resonance imaging; however, available evidence was insufficient to justify recommendations for any specific screening approach. In 2007, the American Cancer Society amended the guideline recommendations for magnetic resonance imaging screening following the release of several studies demonstrating the efficacy of this as a screening tool in such high-risk groups. [27] [28] [29] [30] [31] The updated guidelines recommend yearly magnetic resonance imaging screening as an adjunct to mammography in groups of women at high risk (a Ͼ20 to 25 percent lifetime risk) of developing cancer, a group that includes BRCA mutation carriers and first-degree family members. 24 Evidence was insufficient to recommend magnetic resonance imaging in moderate-risk patients.
Over the years, a number of risk factors have been identified for breast cancer. These include two or more relatives with breast or ovarian cancer, breast cancer occurring before age 50 in an affected relative, relatives with both breast and ovarian cancer, one or more relatives with two cancers, male relatives with breast cancer, or a family history of breast or ovarian cancer and Ashkenazi Jewish heritage.
Although there is insufficient evidence to recommend specific screening guidelines for all women at increased risk, four additional screening options may still be considered: the initiation of mammography screening at age 30, shorter mammography screening intervals, the addition of ultrasound screening, and the addition of magnetic resonance imaging screening for moderaterisk patients.
This study was undertaken to determine the extent to which plastic surgeons are screening patients who present for cosmetic breast surgery using these established guidelines and to investigate the role of practice setting, gender, and years in practice in American Society of Plastic Surgeons member screening practices. Several findings deserve discussion.
Years in Practice
Physicians in practice greater than 15 years were more likely to perform a clinical breast ex- amination than those in practice less than 15 years, but were less likely to begin screening mammograms in patients under 40. Mammography has become a much more widely applied screening tool over the last 15 years, and it is understandable that physicians having trained during the height of emphasis on screening mammography are more likely to obtain a mammogram, whereas physicians who trained before that era would rely more strongly on physical examination. Being in practice for longer than 15 years was an independent predictor of having had patients diagnosed with breast cancer either during or within a year of having a cosmetic breast procedure. This finding is probably due to a greater number of years in practice, resulting in a greater cumulative number of established patients, making any positive finding, including breast cancer, more likely.
Physician Gender
Female physicians were more likely to obtain a preoperative mammogram, more likely to begin screening in younger patients, more likely to screen with multiple modalities, and more likely to obtain an oncology consult. In light of these more aggressive screening practices, it is not surprising that being a female surgeon is an independent predictor of having a patient diagnosed with breast cancer during or within a year of a cosmetic breast procedure. It should be noted, however, that male surgeons were more likely to follow American Cancer Society screening guidelines than their female counterparts, even though these practices seem to result in fewer true-positive breast cancer cases. The reason for the difference in screening practices is not known, although one might speculate that being at risk for breast cancer herself, a female surgeon could possess a degree of countertransference, and thus conduct more aggressive "empathic screening," rather than screening based on American Cancer Society guidelines. This type of conclusion cannot be drawn from the data and is, at best, highly speculative.
Practice Setting
Being an academic practitioner is associated with obtaining an oncology consult as well as obtaining additional screening modalities beyond mammography. This is somewhat expected, as both consult services and imaging modalities are more readily available in academic settings and academic practitioners are more used to relying on them than private practitioners. It is important to note that there was not a difference in adherence to American Cancer Society guidelines, nor was there a difference in the number of patients diagnosed during or within a year of cosmetic breast surgery.
Familiarity with American Cancer Society Guidelines
Surgeons who claimed to be familiar with American Cancer Society guidelines also claimed to screen more aggressively in almost every measured parameter: they were more likely to review risk factors, perform a clinical breast examination, obtain an oncology consult, and order additional screening studies. Importantly, claiming knowledge of American Cancer Society guidelines was an independent predictor of having patients diagnosed with ductal carcinoma in situ or breast cancer during or within a year of a cosmetic breast procedure, suggesting that these more aggressive screening practices result in a greater number of true-positive breast cancer diagnoses.
Limitations
Survey data can suffer from significant recall bias and sample bias. Because the distribution of respondents was fairly even in subgroups compared, sample bias was less likely a serious confounder. Recall bias, however, could have significantly affected the data. For instance, it is very possible that surgeons who think they are familiar with American Cancer Society guidelines also think that they order mammograms more often than they actually do. It is also possible that female surgeons are aware of patients in their practice having been diagnosed with breast cancer within a year of a cosmetic procedure because they are following patients longer or more closely, rather than screening more effectively. It is very difficult to determine the contribution of such effects, but conclusions must be interpreted with this caveat. In addition, the response rate to the online survey was relatively low at 24 percent. As we were unable to make a comparison of our respondents with the overall American Society of Plastic Surgeons membership, it is possible that the respondents represent a subset of the American Society of Plastic Surgeons membership whose practices are not reflective of the whole group. For this reason, conclusions should be interpreted with the appropriate level of caution.
CONCLUSIONS
Breast cancer is a major public health problem, for which screening is at least part of the solution. Plastic surgeons are in a unique position to screen women who may not otherwise receive screening. Knowledge of the American Cancer Society guidelines is an essential component of effective cancer screening, but unfortunately only somewhat more than half of plastic surgeon respondents who perform breast surgery have knowledge of these guidelines. Being male predicted more accurate knowledge of the guidelines, but being female resulted in more aggressive screening, and possibly more diagnoses. Familiarity with the American Cancer Society screening guidelines also resulted in a greater number of perioperative diagnoses. As plastic surgeons, we have an obligation to actively participate in the health and well-being of our patients, and this involves understanding and applying good breast cancer screening practices. 
